Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban

Marc G Romney1, Mark W Hull, Réka Gustafson

  • 1Department of Pathology, Laboratory Medicine, St Paul's Hospital, Providence Health Care, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. mromney@providencehealth.bc.ca

Abstract

Insights

An invasive pneumococcal disease outbreak in Vancouver was linked to Streptococcus pneumoniae serotype 5. Crack cocaine use emerged as a significant risk factor, prompting a need to refine vaccination strategies for vulnerable populations.

Area of Science:

  • Infectious Disease Epidemiology
  • Public Health Surveillance
  • Bacteriology

Background:

  • Invasive pneumococcal disease (IPD) outbreaks are rare, but a surge was observed in Vancouver in 2006.
  • Affected patients, particularly those with severe illness, were concentrated in the Downtown Eastside, an area with high poverty and drug use.
  • This highlighted a potential link between socioeconomic factors and IPD incidence.

Purpose of the Study:

  • To investigate the cause and risk factors of an unusual increase in invasive pneumococcal disease cases.
  • To identify the specific Streptococcus pneumoniae serotype responsible for the outbreak.
  • To evaluate the effectiveness of public health interventions, including vaccination.

Main Methods:

  • Prospective, laboratory-based surveillance for IPD was conducted.
  • On-site serotyping of Streptococcus pneumoniae isolates was performed.
  • Logistic regression analysis was used to identify sociodemographic and medical risk factors associated with IPD.

Main Results:

  • Streptococcus pneumoniae serotype 5 was identified as the predominant cause, accounting for 78% of cases during the outbreak.
  • Crack cocaine use was significantly associated with IPD caused by serotype 5 (OR=12.4).
  • The outbreak strain was susceptible to penicillin but caused substantial morbidity and healthcare system strain.

Conclusions:

  • A targeted vaccination campaign with 23-valent polysaccharide pneumococcal vaccine appeared to contribute to outbreak control.
  • Vaccination strategies in urban areas with high illicit drug use should consider including crack cocaine users.
  • Refined public health approaches are necessary to prevent IPD in at-risk urban populations.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...